首页工具

登录

搜索结果

Search Results for " p38α/β "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T12997	SR-318	p38 MAPK; TNF	Apoptosis; MAPK
	SR-318 是p38 MAPK 的选择性抑制剂，对 p38α，p38β 和 p38α/β 的IC50分别为 5 nM，32 nM 和 6.11 μM。它有效抑制全血中TNF-α的释放，IC50为 283 nM。它显示出抗癌和抗炎活性。
T67944	p38 MAP Kinase Inhibitor Ⅵ	p38 MAPK	MAPK
	p38 MAP Kinase Inhibitor Ⅵ是一种有效的p38 MAP Kinase 抑制剂，具有抗炎活性。
T67830	p38α inhibitor 3	p38 MAPK	MAPK
	p38α inhibitor 3是一种丝裂原活化蛋白激酶P38α的抑制剂，可以有效阻断成肌细胞分化。
T78652	p38α inhibitor 4	p38 MAPK	MAPK
	p38α inhibitor 4 是一种选择性 MAPK p38α抑制剂，看而用于研究糖尿病、疼痛和慢性炎症。
T6496	Vactosertib TEW-7197,EW-7197	ALK; TGF-beta/Smad	Angiogenesis; Stem Cells; Tyrosine Kinase/Adaptors
	Vactosertib (EW-7197) 是有效的、具有 ATP 竞争性的、具有口服活性的激活素受体样激酶 5 (ALK5) 抑制剂(IC50:12.9 nM)。它还以纳摩尔浓度抑制 ALK2 和 ALK4 (IC50为 17.3 nM)，表现出强大的抗转移活性和抗癌作用。
T36010	p38 MAPK Inhibitor	p38 MAPK	MAPK
	p38 MAPK Inhibitor 是p38 MAPK 激酶的有效抑制剂（IC50＝ 35 nM）。p38 MAPK Inhibitor 抑制癌基因RAS 诱导的衰老。
T36012	p38α inhibitor 2
	p38α inhibitor 2 is a highly potent and selective p38α MAPK inhibitor, with a pIC50 of 9.6. p38α inhibitor 2 inhibits the hERG ion channel (IC50=27 μM) and shows a promising selectivity profile when tested in a panel of 51 other protein kinases (<30% inhibition at 10 μM concentration) and a panel of 141 other biological targets[1]. [1]. Raubo P, et al. The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors [published online ahead of pr...
T36011	p38 MAP Kinase Inhibitor IV p38 MAPK Inhibitor IV
	p38 MAPK inhibitor IV is an ATP-competitive inhibitor of p38 MAP kinases with IC50 values of 0.13, 0.55, 5.47, and 8.63 μM for p38α, p38β, p38x, and p38δ, respectively, in vitro.[1] It also inhibits LPS-induced TNF-α and IL-1β cytokine production (IC50s = 22 and 44 nM, respectively) in human peripheral blood mononuclear cells.
T35420	(S)-p38 MAPK Inhibitor III (S)-p38 MAPK Inhibitor III
	(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively).
T79028	p38 Kinase inhibitor 4	p38 MAPK	MAPK
	p38 Kinase inhibitor 4 (compound 135) 是高效的 p38 MAP Kinase 抑制剂，具有显著的生物活性。
T61803	p38 MAPK-IN-3
	p38 MAPK-IN-3 (Compound 2c) is a potent inhibitor of p38α MAPK, displaying antitumor properties by promoting apoptosis and increasing reactive oxygen species (ROS) production [1].
T81441	PLK1/p38γ-IN-1	p38 MAPK	MAPK
	PLK1/p38γ-IN-1（化合物14）为PLK1与p38γ多靶点抑制剂，体外有效抑制人肝细胞癌与肝母细胞瘤细胞增殖。
T2277	Losmapimod GSK-AHAB,GW856553X,6-[5-(环丙基氨基甲酰基)-3-氟-2-甲基苯基]-N-(2,2-二甲基丙基)吡啶-3-甲酰胺,GW856553,洛批莫德,SB856553	p38 MAPK; Autophagy	Autophagy; MAPK
	Losmapimod (GSK-AHAB) 是一种可口服的特异性 p38 MAPK 抑制剂，抑制 p38α 和 p38β 的 pKi 值分别为 8.1 和 7.6。
T6150	TAK-715	p38 MAPK; Casein Kinase; JNK	MAPK; Metabolism; Stem Cells
	TAK-715 是一种具有口服活性的p38 MAPK 抑制剂，对 p38α 和 p38β 的IC50分别为 7.1 nM 和200 nM。它抑制酪蛋白激酶 I (CK1δ/ε)，调节 Wnt/β-catenin 信号传导的激活，有抗炎活性。
T6976	SB 239063 SB239063	p38 MAPK; Autophagy	Autophagy; MAPK
	SB 239063 (SB239063) 是一种选择性、可口服的 p38 MAPK 抑制剂，对重组纯化的人 p38α 的 IC50值为 44 nM，具有抗哮喘作用，还被用于增强因衰老或疾病受损的记忆，如阿尔茨海默病。
T16721	Ralimetinib LY2228820	Others	Others
	Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3.
T18681	SJFα	Others	Others
	SJFα is a 13-atom linker PROTAC. SJFα degrades p38α with a DC50 of 7.16 nM, but is far less effective at degrading p38δ (DC50=299 nM) and does not degrade the other p38 isoforms (β and γ) at concentrations up to 2.5 μM[1].
T70638	p38-α MAPK-IN-5
	p38-α MAPK-IN-5 是一种有效的 p38α抑制剂，对 p38α、p38 β、p38γ、p38δ 的 IC50分别为 0.1 nM、0.2 nM、944 nM、4100 nM。p38-α MAPK-IN-5 具有抗炎作用，并且具有用于哮喘和慢性阻塞性肺病 (COPD) 研究的潜力。
T69898	NG25 trihydrochloride
	NG25 trihydrochloride is a type II kinase inhibitor that inhibits MAP4K2 and TAK1. It also inhibits the Src family kinases Src and LYN and Abl family kinases as well as CSK, FER, and p38α. NG 25 prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectively. NG 25 decreases cell viability of HCT116KRASWT, and to a greater degree of HCT116KRASG13D, colorectal cancer cells in a concentration...
T68321	AS1940477
	AS1940477 is p38 MAPK inhibitor. AS1940477 inhibited the enzymatic activity of recombinant p38α and β isoforms but showed no effect against other 100 protein kinases including p38γ and δ isoforms. In human peripheral blood mononuclear cells, AS1940477 inhibited lipopolysaccharide (LPS)- or phytohemagglutinin A (PHA)-induced production of proinflammatory cytokines, including TNFα, IL-1β, and IL-6 at low concentrations (LPS/TNFα, IC(50)=0.45n M; PHA/TNFα, IC(50)=0.40 nM). In addition, equivalent c...
T36779	NG 25 (hydrochloride hydrate)
	NG 25 is a type II kinase inhibitor that inhibits MAP4K2 and TAK1 (IC50s = 21.7 and 149 nM, respectively).1It also inhibits the Src family kinases Src and LYN (IC50s = 113 and 12.9 nM, respectively) and Abl family kinases (IC50s = 75.2 nM), as well as CSK, FER, and p38α (IC50s = 56.4, 82.3, and 102 nM, respectively). NG 25 (100 nM) prevents TNF-α-induced IKKα/β phosphorylation and IκB-α degradation in L929 cells. It inhibits secretion of IFN-α and IFN-β induced by CpG type B and CL097, respectiv...

化合物

Cat.No: T12997

Target: p38 MAPK, TNF

p38 MAP Kinase Inhibitor Ⅵ

Cat.No: T67944

Target: p38 MAPK

p38α inhibitor 3

Cat.No: T67830

Target: p38 MAPK

p38α inhibitor 4

Cat.No: T78652

Target: p38 MAPK

Cat.No: T6496

Synonym: TEW-7197,EW-7197

Target: ALK, TGF-beta/Smad

p38 MAPK Inhibitor

Cat.No: T36010

Target: p38 MAPK

p38α inhibitor 2

Cat.No: T36012

p38 MAP Kinase Inhibitor IV

Cat.No: T36011

Synonym: p38 MAPK Inhibitor IV

(S)-p38 MAPK Inhibitor III

Cat.No: T35420

Synonym: (S)-p38 MAPK Inhibitor III

p38 Kinase inhibitor 4

Cat.No: T79028

Target: p38 MAPK

Cat.No: T61803

PLK1/p38γ-IN-1

Cat.No: T81441

Target: p38 MAPK

Cat.No: T2277

Synonym: GSK-AHAB,GW856553X,6-[5-(环丙基氨基甲酰基)-3-氟-2-甲基苯基]-N-(2,2-二甲基丙基)吡啶-3-甲酰胺,GW856553,洛批莫德,SB856553

Target: p38 MAPK, Autophagy

Cat.No: T6150

Target: p38 MAPK, Casein Kinase, JNK

Cat.No: T6976

Synonym: SB239063

Target: p38 MAPK, Autophagy

Cat.No: T16721

Synonym: LY2228820

Target: Others

Cat.No: T18681

Target: Others

p38-α MAPK-IN-5

Cat.No: T70638

NG25 trihydrochloride

Cat.No: T69898

Cat.No: T68321

NG 25 (hydrochloride hydrate)

Cat.No: T36779

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼